390 related articles for article (PubMed ID: 17003518)
21. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
[TBL] [Abstract][Full Text] [Related]
22. Antigen-specific regulatory T-cell subsets in transplantation tolerance regulatory T-cell subset quality reduces the need for quantity.
Koenen HJ; Joosten I
Hum Immunol; 2006 Sep; 67(9):665-75. PubMed ID: 17002896
[TBL] [Abstract][Full Text] [Related]
23. Manipulating regulatory T cells: a promising strategy to treat autoimmunity.
Zhang D; Tu E; Kasagi S; Zanvit P; Chen Q; Chen W
Immunotherapy; 2015; 7(11):1201-11. PubMed ID: 26568117
[TBL] [Abstract][Full Text] [Related]
24. Treg Enhancing Therapies to Treat Autoimmune Diseases.
Eggenhuizen PJ; Ng BH; Ooi JD
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977677
[TBL] [Abstract][Full Text] [Related]
25. The therapeutic potential of regulatory T cells for the treatment of autoimmune disease.
Bluestone JA; Trotta E; Xu D
Expert Opin Ther Targets; 2015; 19(8):1091-103. PubMed ID: 25881491
[TBL] [Abstract][Full Text] [Related]
26. Defective selection of thymic regulatory T cells accompanies autoimmunity and pulmonary infiltrates in Tcra-deficient mice double transgenic for human La/Sjögren's syndrome-B and human La-specific TCR.
Yaciuk JC; Pan Y; Schwarz K; Pan ZJ; Maier-Moore JS; Kosanke SD; Lawrence C; Farris AD
J Immunol; 2015 Feb; 194(4):1514-22. PubMed ID: 25582858
[TBL] [Abstract][Full Text] [Related]
27. Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells.
Liu G; Zhao Y
Immunology; 2007 Oct; 122(2):149-56. PubMed ID: 17848162
[TBL] [Abstract][Full Text] [Related]
28. Modulation of regulatory T cell function by monocyte-derived dendritic cells matured through electroporation with mRNA encoding CD40 ligand, constitutively active TLR4, and CD70.
Pen JJ; De Keersmaecker B; Maenhout SK; Van Nuffel AM; Heirman C; Corthals J; Escors D; Bonehill A; Thielemans K; Breckpot K; Aerts JL
J Immunol; 2013 Aug; 191(4):1976-83. PubMed ID: 23842750
[TBL] [Abstract][Full Text] [Related]
29. γδ T Cell-Dependent Regulatory T Cells Prevent the Development of Autoimmune Keratitis.
Huang Y; Yang Z; Huang C; McGowan J; Casper T; Sun D; Born WK; O'Brien RL
J Immunol; 2015 Dec; 195(12):5572-81. PubMed ID: 26566677
[TBL] [Abstract][Full Text] [Related]
30. The PD-1 pathway in tolerance and autoimmunity.
Francisco LM; Sage PT; Sharpe AH
Immunol Rev; 2010 Jul; 236():219-42. PubMed ID: 20636820
[TBL] [Abstract][Full Text] [Related]
31. How do regulatory T cells work?
Corthay A
Scand J Immunol; 2009 Oct; 70(4):326-36. PubMed ID: 19751267
[TBL] [Abstract][Full Text] [Related]
32. In vivo-generated antigen-specific regulatory T cells treat autoimmunity without compromising antibacterial immune response.
Kasagi S; Zhang P; Che L; Abbatiello B; Maruyama T; Nakatsukasa H; Zanvit P; Jin W; Konkel JE; Chen W
Sci Transl Med; 2014 Jun; 6(241):241ra78. PubMed ID: 24944193
[TBL] [Abstract][Full Text] [Related]
33. Regulatory dendritic cells in autoimmunity: A comprehensive review.
Liu J; Cao X
J Autoimmun; 2015 Sep; 63():1-12. PubMed ID: 26255250
[TBL] [Abstract][Full Text] [Related]
34. Instruction of Treg commitment in peripheral T cells is suited to reverse autoimmunity.
Jaeckel E; Kretschmer K; Apostolou I; von Boehmer H
Semin Immunol; 2006 Apr; 18(2):89-92. PubMed ID: 16473523
[TBL] [Abstract][Full Text] [Related]
35. Treg cells in autoimmunity: from identification to Treg-based therapies.
Göschl L; Scheinecker C; Bonelli M
Semin Immunopathol; 2019 May; 41(3):301-314. PubMed ID: 30953162
[TBL] [Abstract][Full Text] [Related]
36. Mycophenolic acid-treated dendritic cells generate regulatory CD4+ T cells that suppress CD8+ T cells' allocytotoxicity.
Kazma I; Lemoine R; Herr F; Chadet S; Meley D; Velge-Roussel F; Lebranchu Y; Baron C
Int Immunol; 2014 Mar; 26(3):173-81. PubMed ID: 24222014
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of Nr4a Receptors Enhances Antitumor Immunity by Breaking Treg-Mediated Immune Tolerance.
Hibino S; Chikuma S; Kondo T; Ito M; Nakatsukasa H; Omata-Mise S; Yoshimura A
Cancer Res; 2018 Jun; 78(11):3027-3040. PubMed ID: 29559474
[TBL] [Abstract][Full Text] [Related]
38. Immunoregulatory function of CD3+, CD4-, and CD8- T cells. Gamma delta T cell receptor-positive T cells from nude mice abrogate oral tolerance.
Fujihashi K; Kiyono H; Aicher WK; Green DR; Singh B; Eldridge JH; McGhee JR
J Immunol; 1989 Dec; 143(11):3415-22. PubMed ID: 2573632
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
Kosiewicz MM; Alard P; Liang S; Clark SL
Int Immunol; 2004 May; 16(5):697-706. PubMed ID: 15096489
[TBL] [Abstract][Full Text] [Related]
40. Recent advances in regulatory T cell therapy of autoimmunity, graft rejection and cancer.
Dunne PJ; Fletcher JM
Recent Pat Inflamm Allergy Drug Discov; 2010 Nov; 4(3):231-43. PubMed ID: 20812898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
